Several brokers issued research notes on Bumrungrad Hospital Public Company Limited, or BH, after attending an analyst meeting, forecasting that third-quarter 2026 performance will grow on recovering international patients and expansion into the new market of Iraq. Asia Plus Securities raised its 2026 net profit estimate to 7.81 billion baht from 7.714 billion baht and lifted its 2027 fair value to 225 baht per share, maintaining a buy rating. Krungsri Securities recommends buying with a target price of 225 baht, despite a neutral view on the revenue direction. KGI Securities raised its 2026 profit forecast by 6.6 percent to 7.87 billion baht and increased its 2027 target price to 228 baht from 218 baht. UOB Kay Hian maintained a buy rating with a target price of 236 baht and named BH a top pick in the hospital sector.
Bumrungrad Hospital PCLBrokers raise profit forecasts and target prices, maintaining buy ratings on BH.
